News|Videos|October 7, 2026

Pharma Rethinks Supply Chain Planning as Disruptions Mount

Name: Why Agility Is Now Table Stakes in Pharma Supply Chains
Uploaded: 2026-10-07T17:17:04.953Z
Duration: PC3M12S
Description: Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.

Author(s)Nitin Jayakrishnan, Stephen Appezzato

Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.

According to Nitin Jayakrishnan, co-founder and CEO of Freehand, disruptions that pharmaceutical supply chains once treated as rare events are now happening almost every quarter. Speaking with Pharmaceutical Commerce at LogiPharma USA 2026, where he joined the keynote panel "Building Resilient Supply Chains at Scale: Preparing for Disruption, Uncertainty & What's Next," Jayakrishnan traces that pace to the COVID-19 pandemic and the run of shocks that followed. These include global tariff wars, armed conflicts, AI-driven volatility and immigration policies affecting companies with global teams.

Related to this article

October 8th, 2026

Supply Chain Visibility Needs Context Before AI, Says PAXAFE’s Mark Talens

At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.

October 7th, 2026

Why Pharma Is Automating for Resilience

At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.

October 6th, 2026

LogiPharma USA 2026: Data Readiness Must Come Before AI

At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.

Mark Beers is vice president of software at Swisslog.

October 6th, 2026

Q&A: Software's Next Role In Pharma Supply Chains

Swisslog's Mark Beers discusses how software helps pharma supply chains adapt to shifting portfolios, strengthen inventory verification and build trust.

October 5th, 2026

Logipharma USA 2026: Building Resilient Supply Chains at Scale

At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains.

Christopher Van Norman is senior vice president of distribution operations at McKesson.

October 5th, 2026

How Distribution Is Evolving for Today's Targeted Therapies

McKesson's Chris Van Norman previews his LogiPharma USA keynote on demand signal sharing, AI, and precision distribution for targeted therapies.

Business and entrepreneurship symposium. Speaker giving a talk at business meeting. Audience in the conference hall. Rear view of unrecognized participant in audience. | © Gennady Danilkin - stock.adobe.com 175466970

October 2nd, 2026

What to Watch at LogiPharma: Resilience, Practical AI and New Peer Formats

LogiPharma's Charleen Ring and McKesson's Chris Van Norman preview the 2026 agenda, sessions to prioritize and a day two fireside chat.

September 24th, 2026

Supply Chain Signal: How Policy Pressures Are Converging on Pharma

Episode 3 of Supply Chain Signal examines the Aug. 31 MFN agreements with nine mid-size manufacturers, the GENEROUS Medicaid model and whether pricing, trade and manufacturing policy now add up to a new pharma operating model.